EE9700166A - Use of melatonin in the manufacture of a medicinal product - Google Patents

Use of melatonin in the manufacture of a medicinal product

Info

Publication number
EE9700166A
EE9700166A EE9700166A EE9700166A EE9700166A EE 9700166 A EE9700166 A EE 9700166A EE 9700166 A EE9700166 A EE 9700166A EE 9700166 A EE9700166 A EE 9700166A EE 9700166 A EE9700166 A EE 9700166A
Authority
EE
Estonia
Prior art keywords
melatonin
manufacture
medicinal product
medicinal
product
Prior art date
Application number
EE9700166A
Other languages
Estonian (et)
Other versions
EE03384B1 (en
Inventor
Zisapel Nava
Original Assignee
Neurim Pharmaceuticals (1991) Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharmaceuticals (1991) Ltd. filed Critical Neurim Pharmaceuticals (1991) Ltd.
Publication of EE9700166A publication Critical patent/EE9700166A/en
Publication of EE03384B1 publication Critical patent/EE03384B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EE9700166A 1995-02-01 1996-01-29 Use of melatonin for the manufacture of a medicament EE03384B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number Publication Date
EE9700166A true EE9700166A (en) 1998-02-16
EE03384B1 EE03384B1 (en) 2001-04-16

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700166A EE03384B1 (en) 1995-02-01 1996-01-29 Use of melatonin for the manufacture of a medicament

Country Status (22)

Country Link
JP (1) JP4516159B2 (en)
CN (1) CN1083263C (en)
AT (1) AT408188B (en)
AU (1) AU695366B2 (en)
BG (1) BG62876B1 (en)
BR (1) BR9607169A (en)
CZ (1) CZ291349B6 (en)
DK (1) DK176081B1 (en)
EE (1) EE03384B1 (en)
FI (1) FI119586B (en)
IS (1) IS1980B (en)
LU (1) LU90118B1 (en)
LV (1) LV11940B (en)
MD (1) MD1716C2 (en)
NO (1) NO312814B1 (en)
NZ (1) NZ298878A (en)
PL (1) PL183148B1 (en)
SI (1) SI9620022A (en)
SK (1) SK284521B6 (en)
TR (1) TR199700723T1 (en)
TW (1) TW483757B (en)
WO (1) WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0016918A (en) 2000-01-05 2004-03-23 Neurim Pharma 1991 Process and formulation for treating antihypertensive resistance and related conditions
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Composition for treating insomnia
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
JP2015509106A (en) 2012-01-26 2015-03-26 ヴァンダ ファーマシューティカルズ インコーポレイテッ Treatment of circadian rhythm disorders
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
ES2805376T3 (en) 2012-12-18 2021-02-11 Vanda Pharmaceuticals Inc Tasimelteon for treating circadian rhythm disorders
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
EP3337462B1 (en) * 2016-10-31 2020-09-30 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0518468T3 (en) * 1991-05-09 2000-01-31 Neurim Pharma 1991 Melatonin-containing compositions
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

Also Published As

Publication number Publication date
FI973185A0 (en) 1997-07-31
TR199700723T1 (en) 1998-02-21
LU90118B1 (en) 1997-11-13
CZ291349B6 (en) 2003-02-12
CN1083263C (en) 2002-04-24
MD1716C2 (en) 2002-02-28
BG62876B1 (en) 2000-10-31
PL183148B1 (en) 2002-05-31
WO1996023496A1 (en) 1996-08-08
DK176081B1 (en) 2006-04-18
TW483757B (en) 2002-04-21
JPH10513177A (en) 1998-12-15
BR9607169A (en) 1997-11-11
LV11940B (en) 1998-05-20
DK89697A (en) 1997-07-30
AU695366B2 (en) 1998-08-13
ATA901396A (en) 2001-02-15
NO973531L (en) 1997-09-30
AU4457496A (en) 1996-08-21
SK284521B6 (en) 2005-05-05
SI9620022A (en) 1998-10-31
CZ240597A3 (en) 1998-01-14
AT408188B (en) 2001-09-25
FI119586B (en) 2009-01-15
SK103097A3 (en) 1998-01-14
MD970254A (en) 1999-05-31
IS1980B (en) 2005-01-14
CN1172431A (en) 1998-02-04
FI973185A (en) 1997-09-30
PL321630A1 (en) 1997-12-08
BG101803A (en) 1998-04-30
MX9705856A (en) 1998-07-31
EE03384B1 (en) 2001-04-16
NO973531D0 (en) 1997-07-31
JP4516159B2 (en) 2010-08-04
NZ298878A (en) 1999-05-28
LV11940A (en) 1998-01-20
IS4532A (en) 1997-07-25
NO312814B1 (en) 2002-07-08
MD1716B2 (en) 2001-08-31

Similar Documents

Publication Publication Date Title
ATE248594T1 (en) MEDICINAL PRODUCT CONTAINING IRBESART
FI954402A (en) New pharmaceutical product
HRP960365B1 (en) New medicaments and the use thereof
DE69632756D1 (en) Skin care products
SG70562A1 (en) Potentiation of drug response
FI942993A (en) Organo-aluminoxy product and use thereof
DE69523440D1 (en) Oral care products
ZA963413B (en) Use of retinoids in a cosmetic composition or for the manufacture of a pharmaceutical composition
DE69516453T2 (en) Skin care products
DE69521692D1 (en) ORAL CARE PRODUCTS
ITMI940884A0 (en) TOPICAL MEDICINAL PRODUCT WITH HEALING ACTIVITY
EE9700166A (en) Use of melatonin in the manufacture of a medicinal product
HUP9901376A3 (en) 1-methylcarbapenem derivatives, their use, production thereof and medicaments containing the same
DK86492D0 (en) PHARMACEUTICAL PRODUCT
LV12067A (en) Use of 17B-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-one in the manufacture of a medicament
DE59610423D1 (en) PARTICULAR MEDICINE
NO962385D0 (en) Therapeutic amides
UA25976C2 (en) ANTI-ULTRASONIC MEDICINAL PRODUCT
FI951041A (en) Use of (S) - (-) - alpha-ethyl-2-oxo-1-pyrrolidineacetamide in the manufacture of a pharmaceutical for the treatment of anxiety
DE29502489U1 (en) Medicinal wrap
DE69315324T2 (en) Oral care products
ID15808A (en) USE OF PROTEASE IN THE MEDICINE
ATE239508T1 (en) PARTICULAR MEDICINAL FORM
SE9203298D0 (en) ANTIDOPAMINE EFFECT MEDICINAL PRODUCT
KR940024222U (en) Manufacture of Medicine Wrapping Paper

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

MM4A Lapsed by not paying the annual fees

Effective date: 20070129